Ainos Inc Stock Today

AIMDW Stock  USD 0.25  0.07  38.89%   

Performance

Solid

 
Weak
 
Strong

Odds Of Distress

Above Average

 
High
 
Low
Ainos is selling for under 0.25 as of the 17th of March 2025; that is 38.89% up since the beginning of the trading day. The stock's lowest day price was 0.085. Ainos has over 57 % chance of experiencing financial distress in the next 2 years of operation, but had a somewhat solid returns during the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
9th of August 2022
Category
Healthcare
Classification
Health Care
Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California. Ainos Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. More on Ainos Inc

Moving together with Ainos Stock

  0.72ETON Eton PharmaceuticalsPairCorr

Moving against Ainos Stock

  0.73ZURA Zura Bio LimitedPairCorr
  0.71ENVB Enveric Biosciences Earnings Call This WeekPairCorr
  0.7PEPG PepGenPairCorr
  0.69PALI Palisade BioPairCorr
  0.67MLTX MoonLake ImmunotherapeutiPairCorr
  0.62IMMX Immix BiopharmaPairCorr

Ainos Stock Highlights

President BoardChunHsien Tsai
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover7.0E-47.0E-4
Notably Down
Slightly volatile
Total Current Liabilities3.2 MM
Significantly Down
Pretty Stable
Non Current Liabilities Total9.8 M9.3 M
Sufficiently Up
Slightly volatile
Total Assets30.3 M28.8 M
Sufficiently Up
Slightly volatile
Total Current Assets4.6 M4.3 M
Sufficiently Up
Slightly volatile
Ainos can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Ainos' financial leverage. It provides some insight into what part of Ainos' total assets is financed by creditors.
Liquidity
Ainos Inc has accumulated 12 M in total debt with debt to equity ratio (D/E) of 3.87, implying the company greatly relies on financing operations through barrowing. Ainos Inc has a current ratio of 0.52, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Ainos' use of debt, we should always consider it together with its cash and equity.

End Period Cash Flow

4.09 Million
Ainos Inc (AIMDW) is traded on NASDAQ Exchange in USA. It is located in 8880 Rio San Diego Drive, San Diego, CA, United States, 92108 and employs 7 people. Ainos is listed under Biotechnology category by Fama And French industry classification. The company classifies itself under Biotechnology sector and is part of Health Care industry. Ainos Inc has accumulated about 1.87 M in cash with (5.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19.
Check Ainos Probability Of Bankruptcy

Ainos Historical Income Statement

At this time, Ainos' Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to climb to about 647.3 K in 2025, despite the fact that Gross Profit is likely to grow to (50 K). View More Fundamentals

Ainos Stock Against Markets

Ainos Corporate Management

HuiLan WuChief OfficerProfile
HsinLiang LeeChief OfficerProfile
Lawrence LinExecutive OperationsProfile
MengLin SungChief OfficerProfile
John EsqCorp CounselProfile

Already Invested in Ainos Inc?

The danger of trading Ainos Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Ainos is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Ainos. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Ainos Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.

Additional Tools for Ainos Stock Analysis

When running Ainos' price analysis, check to measure Ainos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ainos is operating at the current time. Most of Ainos' value examination focuses on studying past and present price action to predict the probability of Ainos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ainos' price. Additionally, you may evaluate how the addition of Ainos to your portfolios can decrease your overall portfolio volatility.